Autolus Therapeutics plc Total Non Current Liabilities 2011-2026 | AUTL

Annual Total Non Current Liabilities Autolus Therapeutics plc

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	50.6 M	23.7 M	601 K	1.03 M	758 K	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
50.6 M	601 K	15.3 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
I-Mab IMAB	131 M	-	-	$ 866 M	China
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Nymox Pharmaceutical Corporation NYMX	368 K	-	-19.68 %	$ 18.4 M	Canada
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	2.21 M	$ 0.9	-2.33 %	$ 6.62 M	China
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	49.6 M	$ 21.96	-0.68 %	$ 3.64 B	USA
RedHill Biopharma Ltd. RDHL	3.48 M	$ 1.02	-0.49 %	$ 428 M	Israel
Allakos ALLK	8.11 M	-	-	$ 28.6 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Aligos Therapeutics ALGS	15 M	$ 6.4	4.4 %	$ 63.3 M	USA
Applied Therapeutics APLT	797 K	-	-	$ 8.42 M	USA
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
Aridis Pharmaceuticals ARDS	854 K	-	17.91 %	$ 11.1 M	USA
Avenue Therapeutics ATXI	2.03 M	-	-52.27 %	$ 4.45 M	USA
Amphastar Pharmaceuticals AMPH	69.4 M	$ 21.41	1.9 %	$ 1 B	USA
Aravive ARAV	10.2 M	-	-13.39 %	$ 1.45 M	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
AstraZeneca PLC AZN	30.8 B	-	-	$ 96.9 B	Britain
BioDelivery Sciences International BDSI	78.7 M	-	-4.8 %	$ 255 M	USA
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
Brainstorm Cell Therapeutics BCLI	618 K	-	-2.5 %	$ 5.88 M	USA
Kazia Therapeutics Limited KZIA	11.6 M	$ 12.26	3.72 %	$ 1.62 B	Australia
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
BioNTech SE BNTX	341 M	$ 105.46	-0.09 %	$ 27.2 B	Germany
BeiGene, Ltd. BGNE	2 B	-	0.49 %	$ 251 B	Cayman-islands
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	90.3 M	$ 4.08	0.25 %	$ 436 M	USA
Arcutis Biotherapeutics ARQT	167 M	$ 23.26	1.75 %	$ 2.96 B	USA
Cara Therapeutics CARA	3.35 M	-	-3.03 %	$ 260 M	USA
Aptose Biosciences APTO	27.9 M	-	-45.71 %	$ 1.2 M	Canada
BioXcel Therapeutics BTAI	1.4 M	$ 1.06	-3.64 %	$ 12.9 M	USA
CASI Pharmaceuticals CASI	38.2 M	-	-	$ 35.4 M	USA
AVROBIO AVRO	276 K	-	1083.1 %	$ 745 M	USA
Cabaletta Bio CABA	43.9 M	$ 2.95	-3.28 %	$ 296 M	USA
Can-Fite BioPharma Ltd. CANF	1.19 M	$ 2.91	-1.36 %	$ 4.79 M	Israel
bluebird bio BLUE	219 M	-	-	$ 546 M	USA
CymaBay Therapeutics CBAY	1.26 M	-	-	$ 3.45 B	USA
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA